Search

Robert H. Havlin

Examiner (ID: 13636, Phone: (571)272-9066 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1639, 1692, 1626, 1609, 1622, 1675
Total Applications
1474
Issued Applications
736
Pending Applications
143
Abandoned Applications
608

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19246766 [patent_doc_number] => 20240197750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => CEFTIBUTEN DOSING REGIMENS [patent_app_type] => utility [patent_app_number] => 18/553769 [patent_app_country] => US [patent_app_date] => 2022-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553769 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/553769
CEFTIBUTEN DOSING REGIMENS Mar 30, 2022 Pending
Array ( [id] => 18085482 [patent_doc_number] => 11535599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-27 [patent_title] => Benzisoxazole derivative [patent_app_type] => utility [patent_app_number] => 17/701539 [patent_app_country] => US [patent_app_date] => 2022-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 34752 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17701539 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/701539
Benzisoxazole derivative Mar 21, 2022 Issued
Array ( [id] => 18631543 [patent_doc_number] => 20230290446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => FEATURIZATION OF CARBON DIOXIDE CAPTURE CHARACTERISTICS IN MOLECULES [patent_app_type] => utility [patent_app_number] => 17/653897 [patent_app_country] => US [patent_app_date] => 2022-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7370 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653897 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/653897
FEATURIZATION OF CARBON DIOXIDE CAPTURE CHARACTERISTICS IN MOLECULES Mar 7, 2022 Pending
Array ( [id] => 19232108 [patent_doc_number] => 20240189299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => ORAL FILM OF CFTR MODULATOR(S) [patent_app_type] => utility [patent_app_number] => 18/549234 [patent_app_country] => US [patent_app_date] => 2022-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8512 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549234 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/549234
ORAL FILM OF CFTR MODULATOR(S) Mar 7, 2022 Pending
Array ( [id] => 19172433 [patent_doc_number] => 20240158407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => METHOD FOR PREPARATION OF AMIDINES [patent_app_type] => utility [patent_app_number] => 18/549406 [patent_app_country] => US [patent_app_date] => 2022-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8861 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 331 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549406 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/549406
METHOD FOR PREPARATION OF AMIDINES Mar 2, 2022 Pending
Array ( [id] => 19386995 [patent_doc_number] => 20240276865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-15 [patent_title] => ORGANOMETALLIC IRIDIUM COMPOUND AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/562194 [patent_app_country] => US [patent_app_date] => 2022-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9099 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 446 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562194 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/562194
ORGANOMETALLIC IRIDIUM COMPOUND AND APPLICATION THEREOF Feb 25, 2022 Pending
Array ( [id] => 19432421 [patent_doc_number] => 20240300919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => A PROCESS FOR PREPARING BATEFENTEROL AND INTERMEDIATES THEREOF [patent_app_type] => utility [patent_app_number] => 18/277340 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7085 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277340 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/277340
A PROCESS FOR PREPARING BATEFENTEROL AND INTERMEDIATES THEREOF Feb 17, 2022 Pending
Array ( [id] => 19265309 [patent_doc_number] => 20240209008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND [patent_app_type] => utility [patent_app_number] => 18/279422 [patent_app_country] => US [patent_app_date] => 2022-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23048 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18279422 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/279422
METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND Feb 3, 2022 Pending
Array ( [id] => 18093445 [patent_doc_number] => 20220411786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => REAGENTS, KITS AND METHODS FOR MOLECULAR BARCODING [patent_app_type] => utility [patent_app_number] => 17/591930 [patent_app_country] => US [patent_app_date] => 2022-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46124 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17591930 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/591930
REAGENTS, KITS AND METHODS FOR MOLECULAR BARCODING Feb 2, 2022 Pending
Array ( [id] => 19065575 [patent_doc_number] => 20240100001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => DENATONIUM SALT FOR USE IN PREVENTING, PREVENTING PROGRESSION AND TREATING FATTY LIVER DISEASES [patent_app_type] => utility [patent_app_number] => 18/274180 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11153 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274180 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/274180
DENATONIUM SALT FOR USE IN PREVENTING, PREVENTING PROGRESSION AND TREATING FATTY LIVER DISEASES Jan 30, 2022 Pending
Array ( [id] => 19448885 [patent_doc_number] => 20240309015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => Methods for the Treatment of Fibrotic Disease [patent_app_type] => utility [patent_app_number] => 18/273646 [patent_app_country] => US [patent_app_date] => 2022-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61310 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -214 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273646 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/273646
Methods for the Treatment of Fibrotic Disease Jan 26, 2022 Pending
Array ( [id] => 19050784 [patent_doc_number] => 20240092753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => PROCESS FOR PRODUCTION OF INTERMEDIATES [patent_app_type] => utility [patent_app_number] => 18/261182 [patent_app_country] => US [patent_app_date] => 2022-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2370 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261182 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/261182
PROCESS FOR PRODUCTION OF INTERMEDIATES Jan 13, 2022 Pending
Array ( [id] => 17734600 [patent_doc_number] => 20220220059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => PROCESS FOR CRYSTALLIZATION OF HIGH PURITY LUTEIN ESTERS FROM MARIGOLD EXTRACTS [patent_app_type] => utility [patent_app_number] => 17/575227 [patent_app_country] => US [patent_app_date] => 2022-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6314 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575227 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/575227
PROCESS FOR CRYSTALLIZATION OF HIGH PURITY LUTEIN ESTERS FROM MARIGOLD EXTRACTS Jan 12, 2022 Abandoned
Array ( [id] => 19018829 [patent_doc_number] => 20240075000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => TREATMENT OF PATHOLOGICAL FATIGUE WITH OXALOACETATE [patent_app_type] => utility [patent_app_number] => 18/272063 [patent_app_country] => US [patent_app_date] => 2022-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19961 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272063 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/272063
TREATMENT OF PATHOLOGICAL FATIGUE WITH OXALOACETATE Jan 12, 2022 Pending
Array ( [id] => 19432413 [patent_doc_number] => 20240300911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => PURIFICATION METHOD FOR CITALOPRAM OR S-CITALOPRAM [patent_app_type] => utility [patent_app_number] => 18/261480 [patent_app_country] => US [patent_app_date] => 2022-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2749 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18261480 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/261480
PURIFICATION METHOD FOR CITALOPRAM OR S-CITALOPRAM Jan 9, 2022 Pending
Array ( [id] => 19448848 [patent_doc_number] => 20240308978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY [patent_app_type] => utility [patent_app_number] => 18/271192 [patent_app_country] => US [patent_app_date] => 2022-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26138 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 699 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271192 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/271192
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY Jan 6, 2022 Abandoned
Array ( [id] => 17656933 [patent_doc_number] => 20220177398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => Industrial Process for Manufacturing of Perfluoro (Methyl Vinyl Ether)(PFMVE) and of 2-Fluoro-1,2-Dichloro-Trifluoromethoxyethylene (FCTFE) [patent_app_type] => utility [patent_app_number] => 17/565492 [patent_app_country] => US [patent_app_date] => 2021-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17855 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17565492 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/565492
Industrial Process for Manufacturing of Perfluoro (Methyl Vinyl Ether)(PFMVE) and of 2-Fluoro-1,2-Dichloro-Trifluoromethoxyethylene (FCTFE) Dec 29, 2021 Abandoned
Array ( [id] => 19464017 [patent_doc_number] => 20240317686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/270664 [patent_app_country] => US [patent_app_date] => 2021-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42497 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270664 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/270664
RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Dec 28, 2021 Abandoned
Array ( [id] => 19034057 [patent_doc_number] => 20240083872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY [patent_app_type] => utility [patent_app_number] => 18/269692 [patent_app_country] => US [patent_app_date] => 2021-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36191 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 595 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269692 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/269692
Cyclic amine derivatives having serotonin receptor binding activity Dec 26, 2021 Issued
Array ( [id] => 18987719 [patent_doc_number] => 20240059688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => CONOLIDINE ANALOGUES AS SELECTIVE ACKR3 MODULATORS FOR THE TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 18/258873 [patent_app_country] => US [patent_app_date] => 2021-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47704 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258873 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/258873
CONOLIDINE ANALOGUES AS SELECTIVE ACKR3 MODULATORS FOR THE TREATMENT OF CANCER Dec 21, 2021 Pending
Menu